CION Cancer Clinics
Why cancer treatment often waits until the jaundice settles | CION Cancer Clinics
Many cancer medicines are cleared by the liver and the bile. When bilirubin is high, they can build up and push a strained liver towards failure, so treatment usually waits until a stent or drain has brought the jaundice down. This page explains why, what happens during the wait, when the wait does not apply, and which signs mean going to hospital the same day. At CION Cancer Clinics, our team supports patients and families through symptoms, follow-up and life during and after treatment.
On this page
- Why will the doctor not start chemotherapy while I am jaundiced?
- What makes a high bilirubin risky during treatment?
- What happens between the stent and the first treatment?
- Four things families worry about during the wait
- Does treatment always have to wait for the jaundice?
- What this page cannot tell you
- Common questions about waiting for jaundice to settle
The short answer
Why will the doctor not start chemotherapy while I am jaundiced?
Because many cancer medicines are cleared from the body by the liver and the bile. When bilirubin is high, those medicines can build up to harmful levels, and a liver already under strain can be pushed into failure. Waiting for the jaundice to settle, usually after a stent or a drain, makes treatment safer and often makes it possible at all.
The wait is part of the plan, not a delay
Families often feel that every day without treatment lets the cancer grow. That fear is understandable. In practice, starting strong treatment on a liver that cannot cope can cause more harm in a few weeks than the cancer would. The team is protecting your chance of having the full treatment, not losing it.
Who this page is for
This page is for people with primary liver cancer, bile duct cancer, or cancer that has spread to the liver, who have been told treatment must wait for the bilirubin to fall. It applies to chemotherapy, targeted therapy, immunotherapy and to procedures such as TACE.
Bilirubin is the yellow pigment measured in your liver function test. It is the number your team is watching.What the team weighs
What makes a high bilirubin risky during treatment?
Your oncologist is balancing three things at once. A high bilirubin tips all three the wrong way.
How the medicine leaves your body
Several chemotherapy drugs, and some targeted tablets, are broken down by the liver or passed out in bile. With the bile blocked, the medicine stays in the blood longer and side effects become stronger and less predictable.
How much liver is left in reserve
Treatment can briefly stress the liver. A healthy liver absorbs that. A liver already struggling with blocked bile, cirrhosis or tumour may not, and liver failure is hard to reverse.
The risk of infection
Bile that cannot drain can become infected. Chemotherapy lowers the white cell count, which makes that infection far more dangerous. The blockage is cleared first so the two risks do not meet.
Why this matters
- Infection in the bile ducts can become serious quickly
- A low white cell count hides the usual warning signs
Why the cause of the jaundice matters
If a blockage is causing it, a stent can bring bilirubin down. If the liver itself is failing, there is nothing to unblock. The answer decides whether waiting will help. Our page on the two causes of jaundice explains how they are told apart.
Not sure whether this applies to you?
Ask an oncologistWhile you wait
What happens between the stent and the first treatment?
The blockage is relieved
A stent or a drain is placed at a partner hospital to let bile flow again. Our page on stenting or drainage explains the options.
Blood tests are repeated
Bilirubin is checked at intervals your team sets. A steady fall is what everyone is looking for. A fall that stalls is a reason to look at the stent again.
The rest of the work-up goes on
The wait is rarely wasted. Biopsy results, molecular testing for bile duct cancer, staging scans and the tumour board discussion often happen in the same weeks.
Strength is built up
Eating well, staying active and treating the itching all matter now. Protein is usually needed, not cut back. Ask before restricting any food.
The plan is confirmed
Once bilirubin is low enough for that particular treatment, your oncologist confirms the start date and explains any change to the doses.
While you are waiting with jaundice or a new stent, go to hospital today if there is fever or shivering, new confusion or drowsiness, vomiting blood or passing black stools, or a drain that suddenly stops working. Tell the doctor about the cancer and the stent. These need treatment the same day.
Commonly believed
Four things families worry about during the wait
The wait is usually short and planned. Treatment given too early on a jaundiced liver can cause serious harm and end treatment altogether. Most teams use the time to complete the tests that the treatment decision needs.
No herbal remedy opens a blocked duct, and some herbs can injure a liver that is already strained. Please tell your oncologist about anything you are taking. Nobody will judge you for it, and it may matter for the treatment plan.
Doctors go by the blood test, not the colour of the eyes. Bilirubin can fall to a safe level while some yellowness still shows, so the start date may come sooner than you expect.
Strong treatment may not be safe. Care still continues: the itching, pain, appetite and comfort can all be treated, and palliative care can start alongside any decision.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Not every case
Does treatment always have to wait for the jaundice?
Not always. Some treatments are given with lower doses when bilirubin is only mildly raised, and some medicines depend less on the liver than others. Your oncologist chooses the drug and the dose with your blood results in hand. General advice about chemotherapy and the liver is covered on our page about chemotherapy with liver disease.
When the jaundice will not settle
When jaundice comes from liver failure rather than a blockage, waiting will not bring it down. In that situation, the question changes. Active cancer treatment may carry more harm than benefit, and the focus moves to comfort and quality of life. That is a hard conversation, and you are entitled to ask for it plainly and to bring family members into it.
Jaundice that appears during treatment
This page is about jaundice before treatment begins. If jaundice starts while you are already on immunotherapy or chemotherapy, contact your team the same day. It may be a side effect rather than the cancer.
Being straight with you
What this page cannot tell you
It cannot tell you how long your own wait will be, or what bilirubin level your treatment needs. Those depend on the medicine chosen, the cause of the jaundice and how your liver is working overall. The threshold differs from one drug to the next, so ask your oncologist which number they are waiting for and why.
It cannot read your blood report
A liver function test has several numbers that move together. Reading one in isolation can mislead. Our page on reading a liver function test explains each one, but your team should interpret your own results.
Who to ask
If the wait feels long or unexplained, ask for a clear plan in writing: what is being waited for, and what happens if it does not come. A second opinion is reasonable. CION's oncologists review reports, discuss them at the tumour board and coordinate stenting with partner hospitals.
Questions we are asked
Common questions about waiting for jaundice to settle
How long does it take bilirubin to come down after a stent?
It varies. When the stent drains well, bilirubin usually starts falling within days and keeps falling over the following weeks. A higher starting level takes longer. If it stalls, the team will check whether the stent is working or whether part of the liver is still blocked.
Will the cancer grow while we wait?
It may, slowly, over a short wait. Your team weighs that against the much greater risk of starting treatment on a liver that cannot handle it. If the wait becomes long, ask whether a treatment that depends less on the liver could start sooner.
Does this apply to immunotherapy too?
Often, yes. Immunotherapy can itself inflame the liver, and a raised bilirubin at the start makes that harder to spot and manage. Your oncologist decides case by case. Our page on jaundice during immunotherapy covers the warning signs.
Can TACE be done while I am jaundiced?
Usually not. TACE deliberately cuts off blood to part of the liver, and a liver already failing to clear bile may not recover from that. Your team will want the jaundice treated or explained first, and will tell you if TACE is no longer safe.
What should we eat during the wait?
Regular meals with enough protein and calories, unless a doctor has said otherwise. Cutting protein is a common family habit that weakens patients. Bile helps digest fat, so smaller, lower-fat meals may sit better until the stent is working. Ask for a dietitian review.
Can anything be done for the itching meanwhile?
Yes. Draining the bile is the most effective step, and medicines and skin care help while it works. Itching is often under-treated, so say clearly how much it is affecting sleep. Our page on itching and what helps lists the options.
Why does the doctor keep asking about alcohol and herbs?
Because both affect how the liver handles treatment. The question is about safety, not blame. An honest answer helps the team choose the right medicine and dose. Many patients hide drinking or tonics out of embarrassment, and it is always better to tell.
Can I get a second opinion during the wait?
Yes, and the wait is often a sensible time for it. Bring the scans, the biopsy report and the recent blood tests. CION's team can review them, discuss them at the tumour board and explain what the bilirubin needs to reach before treatment.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Sources
- MedlinePlus — Liver Function Tests
- American Cancer Society — Palliative Therapy for Bile Duct Cancer
- American Cancer Society — Chemotherapy for Liver Cancer
- Merck Manual Consumer Version — Jaundice in Adults
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Unsure why treatment has not started yet?
Send us the latest blood tests and scans, and an oncologist will explain what the team is waiting for and what the plan is once it comes. One helpline serves every CION centre.